Clinic Valuation
$8.42M
+12.8%
vs. initial indication
Acquisition command center
Portfolio Intelligence
Executive visibility across clinic valuations, operating performance, diligence, and transaction readiness.
Illustrative data
As of today
Priority acquisition target
Northstar Metabolic
Transaction stage
Diligence
Investment score
86 / 100
Trailing 12-Month Revenue
$6.14M
+18.4%
year over year
EBITDA Margin
27.6%
+320 bps
operating expansion
Deal Readiness
86/100
12 items
remaining in diligence
Enterprise value trajectory
Northstar Metabolic
Current indication
$8.42M
Period movement
+$1.09M
Implied multiple
5.0×
Active opportunities
Acquisition Candidates
6 clinics
| Clinic | Stage | TTM revenue | EBITDA | Valuation | Score | Actions |
|---|
Conversion funnel